Purpose Surveillance after colorectal cancer (CRC) treatment is routine, but intensive follow-up may offer little-to-no overall survival benefit. Given the growing population of CRC survivors, we aimed to systematically evaluate the literature for the patient perspective on two questions: (1) How do CRC patients perceive routine surveillance following curative treatment and what do they expect to gain from their surveillance testing or visits? (2) Which providers (specialists, nursing, primary care) are preferred by CRC survivors to guide posttreatment surveillance? Methods Systematic searches of PubMed MEDLINE, Embase, the CENTRAL Register of Controlled Trials, CINAHL, and PsycINFO were conducted. Studies were screened for inclusion by two reviewers, with discrepancies adjudicated by a third reviewer. Data were abstracted and evaluated utilizing validated reporting tools (CONSORT, STROBE, CASP) appropriate to study design. Results Citations (3691) were screened, 91 full-text articles reviewed, and 23 studies included in the final review: 15 quantitative and 8 qualitative. Overall, 12 studies indicated CRC patients perceive routine surveillance positively, expecting to gain reassurance of continued disease suppression. Negative perceptions described in six studies included anxiety and dissatisfaction related to quality of life or psychosocial issues during follow-up. Although 5 studies supported specialist-led care, 9 studies indicated patient willingness to have follow-up with non-specialist providers (primary care or nursing). Conclusions Patients' perceptions of follow-up after CRC are predominantly positive, although unmet needs included psychosocial support and quality of life.
Introduction
Colorectal cancer (CRC) remains the third most common cancer in the USA. [1] With the 5-year survival rate reaching 90% among patients with localized disease, there are an estimated 1.4 million CRC survivors in the USA. [2] This growing population of cancer survivors provides incentive for improving healthcare delivery. In 2005, the Institute of Medicine released a report to improve the care provided to cancer survivors, increasing awareness of medical, functional, and psychosocial needs throughout survivorship. [3] After curative treatment, recommended CRC surveillance varies with a combination of office visits, laboratory tests, imaging, and endoscopy. With a range of different surveillance guidelines [4] [5] [6] [7] [8] [9] , the optimal strategy is controversial.
Receipt of follow-up care is highly variable, characterized by both over-and under-treatment. Adherence to surveillance guidelines ranges from 12 to 87% [10] . Furthermore, many patients receive non-recommended tests for metastatic disease during follow-up [11, 12] .
Surveillance aims to detect recurrence or new disease at a sufficiently early stage to facilitate curative treatment, presumably to reduce mortality. Among CRC survivors, recurrence rates vary from 10 to over 50% dependent upon patient and tumor-related prognostic factors [13] [14] [15] , Recent evidence suggests that intensive follow-up strategies have little or no effect on overall survival, although they may detect recurrence earlier with more salvage surgery [15, 16] . Without a clear survival benefit, these studies call into question the current paradigm of follow-up care. Surveillance may pose risks for over-diagnosis and the need for invasive procedures. Moreover, it can lead to significant anxiety. For the 1.4 million CRC survivors in the USA, intensive follow-up may detect only a small number of recurrent cases, with a smaller proportion eligible for resection and an even smaller number achieving cure.
The growing population of cancer survivors and evolving concepts of survivorship care necessitates a full understanding of patient preferences. Given the lack of clarity on optimal surveillance and widely variable receipt of follow-up care and a need to re-focus care on patient-centered priorities, CRC survivors can provide critical insight into surveillance care. Though systematic reviews have examined survival benefits and adherence patterns associated with colorectal cancer surveillance, there is no systematic review of the patient perspective. The aim of this systematic review was to explore the literature for two key patient-centered questions: (1) How do CRC patients perceive routine surveillance following curative treatment and what do they expect to gain from their surveillance testing or visits? (2) Which types of providers are preferred by survivors to guide post-treatment surveillance?
Methods

Search strategy
This systematic review was guided by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The study protocol was published online in the Prospero International prospective register of systematic reviews [17] . The search strategy was developed by study authors (JB, AC, GC, LO) and run by LO in the following databases: MEDLINE (pubmed.com), Embase (embase. com), Cochrane Central Register of Controlled Trials (CENTRAL) on the Wiley platform, CINAHL (Ebsco), and PsycINFO (Ebsco). Search strategies were adapted for each database from the MEDLINE search strategy (See Online Resource 1). All databases were searched back to their inception; no language or date limits were applied. The search included combinations of terms for colorectal cancer, patient perceptions, and surveillance or follow-up. Patient perception terms included attitudes, expectations, reactions, opinions, and acceptance. Surveillance or Bfollow-up^focused on the receipt of surveillance monitoring, continuity of care, and survivorship care for CRC patients following initial treatment.
Inclusion and exclusion criteria
Studies were considered eligible if they included (1) a population of adults (age ≥ 18 years) who had undergone treatment, including surgical resection, for CRC of all stages; (2) data on patient perceptions or expectations of care; (3) surveillance care in the form of follow-up visits, imaging, blood tests, and/or colonoscopy; and (4) primary study data (not a review, editorial, or commentary). Articles that focused on CRC Bsurveillance^or Bscreening^in the setting of inflammatory bowel disease, familial adenomatous polyposis, or hereditary nonpolyposis CRC/Lynch syndrome were not considered eligible. Articles were excluded if they failed to provide patient perspectives on surveillance, were not about surveillance care, or were abstracts only. A pilot screen of the first 100 citations from the search strategy was performed to refine criteria and ensure consistency between raters. All articles, including the first 100, were subject to the final inclusion and exclusion criteria.
Selection of studies
Studies were selected through a multi-step process. Two reviewers (JB and AC) independently reviewed titles and abstracts, categorizing articles as BYes,^BNo,^or BMaybe^with regard to full-text review. Articles marked BYes^or BMaybeŵ ere moved to full-text review, performed independently by both reviewers to determine final inclusion in the study. Discrepancies between reviewers were adjudicated through discussion until consensus was reached or referred to a third reviewer (GC) as a tie-breaker.
Data extraction
Two reviewers (JB and AC) extracted relevant information regarding the study country of origin, patient population, eligibility criteria, duration of follow-up, study design, analysis, and results. One reviewer completed the extraction while the other verified abstracted data.
Quality of evidence
Quality assessments were completed using standard frameworks: the CONSORT and STROBE checklists were applied to randomized and observational studies, respectively; qualitative articles were assessed according to criteria on the CASP tool [18] . Using the STROBE and CONSORT checklist, studies were assessed for completeness of reporting on each element, rating each according to the following criteria: Byes, explicitly reported by study authors,^Binferred by raters but not explicitly reported by study authors,^or Bno, not reported by study authors.^Using the CASP tool, there were nine components assessed according to: Byes,^Braters unable to determine,^or Bno^.
Results
Searches returned a total of 3691 articles for title/abstract screen, with 91 selected for full-text review; 23 studies were included in the final review (Fig. 1) . These latter included 15 quantitative and 8 qualitative studies conducted across the USA (3 studies), United Kingdom (8), Italy (2), Denmark (1), Netherlands (2), Sweden (1), Canada (3), and Australia (3), (Table 1) . Among the 15 quantitative studies, the most common research design was a cross-sectional survey (n = 10). Among the 8 qualitative studies, 4 utilized semistructured interviews. The 23 studies were published between 1997 and 2014. All included CRC patients who had undergone treatment, with 4 studies including other cancer types.
Quality of evidence
There was variability in the quality of evidence across studies. Of the 15 quantitative studies, 13 were observational studies assessed with the STROBE checklist. These ranged in quality from low (5 of 22 STROBE elements) to high (21 of 22) . Two randomized trials were assessed with the CONSORT checklist, both reported 16 of 22 CONSORT elements. The 8 qualitative studies were assessed with the CASP tool, ranging in quality from low (5 of 9 CASP elements) to high (9 of 9). The most consistent weakness among the qualitative studies was lack of consideration regarding the relationship between the researcher and the participants (7 studies). (See Online Resource 2) Question 1: patient perceptions of routine surveillance Sixteen studies provided information regarding patient perceptions and expectations of routine surveillance after treatment for CRC. Findings pertaining to both positive and negative perceptions of surveillance are summarized in Table 2 .
Twelve (75%) of the 16 studies identified positive perceptions of CRC surveillance. Positive perceptions included high rates of overall satisfaction with follow-up care [19, 31, 32, 36] , with one study identifying a correlation between longer patient-physician relationship and perceived quality of followup care [19] . Compared to an infrequent follow-up group, Beaver 2010 [21] In-depth interviews N = 27, CRC pts., mean time from dx 26 months UK (England) To explore pt. perceptions of experiences of FU care after treatment for CRC The dominant theme (Bknowing what to expect^) emerged with sub-themes (living with altered bowel function, learning through trial and error, and information and support from specialist nurses). The colorectal nurse specialist was considered vital for continuity of care and tailoring information to individuals.
Beaver 2011 [22] CS survey N = 187 CRC pts., mean time from dx 34.9 months UK (England) To explore pt. satisfaction on different aspects of FU service provision following treatment for CRC and amenability to an alternative strategy for FU care There were high rates of satisfaction on most outcomes, but suboptimal satisfaction related to genetic risk, sexual attractiveness, and self-care. There was high satisfaction with nurse specialists and acceptance of nurse-led telephone FU.
Browne 2011 [23] Semi-structured interviews N = 19, CRC pts., FU at 12-months after dx UK (Scotland) To explore CRC pts' experiences of psychosocial problems and their management in primary and specialist care Physical, psychological, and social needs were identified.
Participants noted GPs were less involved but still provided support after treatment; the clinical nurse specialists provided continuity and psychological support.
Cardella 2008 [24] Retrospective cohort N = 96, CRC pts., median FU 34 months
Canada
To evaluate compliance with a CRC FU protocol adopted by a multidisciplinary gastrointestinal cancer group, to describe pt. and physician perspectives on CRC FU, and to examine perceived barriers to adherence with CRC FU Guideline surveillance targets were met for 70% of clinic visits, 49% of carcinoembryonic antigen (CEA) determinations, and 62% of imaging studies. Barriers to FU included access to testing and confusion about which provider ordered investigations.
DiFabio 2008 [25] CS survey N = 62, CRC pts., mean 37. Elderly, less educated pts. preferred GP follow up. No difference in HR-QOL between GP and surgeon groups; no difference in anxiety or depression; pts. were highly satisfied in both arms.
Hall 2011 [27] Kjeldson 1999 [28] CS survey N = 320, CRC pts., mean time since surgery 7.1 years
Denmark
To evaluate the influence of FU examinations after curative surgery for CRC on health-related quality of life (HR-QOL) and to assess the attitude of the pts. to FU Pts with more intense (every 6 months) FU had greater confidence in the check-ups compared with less-intensive (every 5 years). HR-QOL was marginally better (non-significant) for those with intense FU.
LiDestri 2000 [29] Prospective cohort N = 100 CRC pts., mean FU duration 38. patients with more frequent follow up visits had greater confidence in the visits and believed that such follow-up care could improve survival [28] . The majority of patients believed that evaluation for recurrence was the most important reason for follow up [25, 32] . Patients valued receipt of tangible information regarding their disease and surveillance [22, 39] and desired providers to review the information with them, including the nature of tests and frequency of visits [39] . When examined, issues of access to care and frequency of visits were satisfactory [19, 31, 36] . Several articles emphasized that patients receive emotional reassurance from follow-up [24, 28, 31, [33] [34] [35] [36] . Follow-up tests that confirmed the absence of disease were highly valued, described in one qualitative study as Bbetter than winning the lottery^ [33] . Most patients reported no more anxiety than usual the week before a visit [31] ; fear and worry over follow-up testing was rare [34, 35] .
Several studies directly compared the potential stressors of follow-up to the benefits, finding that the stress and anxiety of follow-up tests was perceived as minimal for the benefit received by routine surveillance visits [24, 31, 34, 36] . In a study focused on carcinoembryonic antigen (CEA) testing, patients explicitly wanted to continue tests despite the possibility of false positive results and stated they would want to be informed of a recurrence even if it were incurable [34] . Similarly, patients reported a desire to continue regular follow-up visits with their physician regardless of survival benefit and wished to be informed of a recurrence, even if there were no survival or treatment benefit offered [31] .
Six (37.5%) of the 16 studies described negative perceptions of follow-up. These included anxiety or stress related to follow-up visits or tests, unmet expectations regarding information exchange, lack of psychosocial evaluation and emotional support, and overall dissatisfaction. Patients felt they were not encouraged to ask questions and did not receive satisfactory answers, with most noting that physicians lack knowledge of how CRC affects quality of life [19] . Patients were dissatisfied with available information regarding how treatment would affect their body and sexuality, communication between providers, and the extent to which their family was included and considered in care planning [22] . Some patients experienced anxiety and stress associated with follow-up [29, 33] ; concern over cancer recurrence was worse among patients with young children [34] . Patients often displayed a state of Bguarding^associated with anxiety about recurrence, loss of confidence in health, and perceived loss of control over one's body [38] . Patients felt that evaluating unpleasant emotional states (including anxiety, restlessness, and depression) was an important part of follow-up, a priority not shared among surgeons [25] . Though the majority of patients wanted counseling from their physicians, only a minority received such counseling [30] .
Question 2: patient preference for delivery of surveillance by provider type The question of surveillance care delivery was addressed by 14 studies (Fig. 2 ). There were 8 quantitative and 6 qualitative study designs, and study findings for this set were heterogeneous. Studies addressed the perceived role of the following three provider types: specialist nurse, the general (GP) or family practitioner (FP), or the specialist (surgeon or oncologist). None suggested complete exclusion of the specialist. Five studies suggested patients were open to or supportive of nurse-led follow-up [20] [21] [22] [23] 37] . Benefits to nurse-led follow up included improved access to care, continuity, patient education, and perceived support in coping with their disease [21, 23] . Four studies suggested willingness to engage the GP or FP in a larger role in follow-up [26, 27, 33, 40] . This was particularly favored among patients who endorsed a strong patient-physician relationship with their GPs N no. of articles with emphasis on positive/negative perceptions according to the stated theme (row) [33] ; however, some patients expressed concern about losing contact with specialists [27] . Finally, five studies demonstrated a preference for specialists [31, 35, 36, 39, 41] . Regardless of having an engaged GP or FP, patients found comfort in the authority and expertise associated with specialist care [39] . Patient satisfaction with follow-up was generally high regardless of the type of provider delivering surveillance care. There were three studies examining quality of life (QOL) as an outcome [26, 36, 40] and one examining healthcare resource utilization and patient safety [37] . Frequency and timing of follow-up visits did not affect QOL [36] . Comparing GP-led and surgeon-led follow-up, there was no difference in health-related quality of life, anxiety, or depression [26, 40] . Compared to surgeon-led follow-up, nurse-led follow up was associated with longer consultation times and more blood tests, though there was no difference in radiologic studies ordered [37] .
Discussion
Post-treatment CRC surveillance monitors patients for the development of recurrence, promotes prevention and health maintenance, and provides important emotional and psychosocial support. The 23 articles identified in this systematic review offered insight into patient perspectives on surveillance after CRC treatment. The articles originated from a diverse range of countries using a variety of methodologies. Overall, positive perceptions predominated, with follow-up providing emotional reassurance of being cancer-free. Patients reported high satisfaction with follow-up and believed that continued follow-up was important for the detection of recurrence. There were widely variable preferences for a given type of provider to conduct follow-up surveillance; however, satisfaction was generally high regardless of care by specialists, primary care providers, or nurse specialists.
Reassessing the patient perspective on survivorship and follow-up has wide-reaching, international importance. In the USA, the Patient-Centered Outcomes Research Institute (PCORI) places emphasis on patient-centered clinical comparative effectiveness research. Three studies from the USA [19, 32, 35] were included in this review, all demonstrating positive perceptions of surveillance care, with two of the three identifying room for improvement in patient education and information exchange [32, 35] . The National Health Service in the United Kingdom begins its manual on CRC services with a chapter concerning patient-centered care [42] . This review included eight studies from the United Kingdom [21-23, 27, 31, 33, 34, 38] , with findings that reflect a wide range of patient perspectives, from the positive role of reassurance [31] to the anxieties and guarding experienced by survivors [38] . A Canadian report called for better identifying survivors' needs during follow-up, developing and implementing appropriate models for care, and increasing collaboration between the healthcare system and the community. [43] Three Canadian studies [24, 30, 39] underscore the positive importance of follow-up for CRC survivors and the need to improve patient education. Given high survival rates and an aging global population, many countries have responded with a renewed focus on the patient.
The optimal follow-up strategy after treatment for CRC remains controversial. A 2016 Cochrane systematic review of 5403 CRC patients in 15 randomized controlled trials found that despite more salvage surgery with intensive follow-up, there was no significant difference in overall or relapse-free survival compared with less-intense follow-up [16] . From the specialist provider's perspective, follow-up for the detection of local recurrence or distant metastasis may not be justified if increased intervention has no effect on survival. In contrast, the patient perceives follow-up for a complimentary, but not identical, purpose-confirmation of a disease-free state, the value of which extends beyond survival alone. Primary care providers and specialist nurses could potentially bridge this gap; however, there is considerable variability in perceived roles and responsibilities among PCPs and specialists regarding surveillance care [44] . A survey of cancer specialists in Canada found that at least half believed primary care providers may better deliver psychosocial support for colorectal cancer survivors [45] . In a nationally representative US sample, approximately half of oncologists and primary care providers self-report providing broad psychosocial care to cancer survivors; however, both groups saw themselves as the main providers [46] . Beyond the need to educate providers, improved survivorship care will require better coordination and delineation of different roles in multidisciplinary management. Furthermore, this review identified variability in preferences for specialist, nurse, and GP-led surveillance yet persistently high rates of satisfaction for different provider types across studies. Opportunities for future work exist in educating patients about the potential roles for multiple different provider types and further evaluating patient perspectives on their follow-up needs. Research on decision-making interventions must incorporate patient perspectives, as tools that rely solely on the likelihood of recurrence, and potential for cure may inadequately address survivorship needs. The follow-up visit presents an opportunity to fulfill unmet patient needs after treatment for CRC. Beyond reassurance that patients remain cancer-free, the visit provides an opportunity for education, rather than delivery of a binary answer. Many patients are unaware how recurrence risk changes over time. For example, conditional survival of stage IIIC colon cancer improves dramatically from 42 to 80% over the first five posttreatment years [47] , with similar improvements in rectal cancer [48] . This review identified room for improvement in information exchange, sensitivity toward psychosocial and quality of life issues, and emphasis on general health maintenance and prevention. Failure to address psychosocial concerns can have significant health consequences on depression and anxiety [49] , quality of life [50] , adherence to recommended surveillance protocols [51] , and even survival [52] [53] [54] . The Institute of Medicine has highlighted psychosocial care as a critical component of survivorship care [3] and subsequently produced important guidance on the development and implementation of survivorship care plans [55] . Key areas for improvement at the provider-level may include better coordination in follow-up visits, utilizing multidisciplinary healthcare professionals to implement screening for psychosocial distress, and better tailoring follow-up care to the individual patient [56] . Further advances may require engagement of professional organizations in developing and disseminating coordinated efforts such as best practice guidelines. [57] Finally, incorporating patient priorities into survivorship care demands continued focus on better understanding patient perspectives. This review identified studies with wide-ranging quantitative and qualitative methodologies; however, many quantitative studies focused predominantly on satisfaction and quality of life. The field of survivorship care, including its related literature, may benefit from research that expands beyond these concepts, reaching to improve processes of care (e.g., individualized decision support tools) and outcomes that matter most to patients (e.g., patient-reported outcomes). Focusing on patient-centered priorities may provide new purpose for routine follow-up care in the face of equivocal survival outcomes.
This study has several limitations. First, the generalizability of these findings across healthcare systems is uncertain. Single vs multi-payer systems differ significantly in the distribution of costs; single-payer systems have greater incentive to maximize the role of primary or nursing care. Hence, our findings related to patient preferences for a given provider type may have less direct relevance in the USA, where not all patients have access to primary care. Second, patient perspectives are subjective endpoints, posing a challenge to the reproducibility of our review. We attempted to minimize bias with the development of a review protocol [17] and by conducting the review in duplicate. Third, use of qualitative studies in a systematic review is challenging. Despite debate, qualitative studies can provide critical data otherwise unrepresented through quantitative methodologies [58] [59] [60] .
In conclusion, this systematic review indicates that CRC patients hold a positive view of follow-up care as a mechanism to provide reassurance. However, there is a persistent need to improve patient-centeredness by enhancing communication about the expectations for surveillance and increasing sensitivity to psychosocial and quality of life concerns. 
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